|
Market Closed -
Nasdaq
01:00:00 07/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 3.610 USD | +3.74% |
|
-5.50% | -49.01% |
Company Valuation: Bicycle Therapeutics plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,790 | 878.8 | 767 | 966.6 | 491.1 | 243.9 | - | - |
| Change | - | -50.89% | -12.72% | 26.03% | -49.19% | -50.33% | - | - |
| Enterprise Value (EV) 1 | 1,381 | 570 | 280.6 | 91.11 | -122.9 | -268.9 | -159.4 | -40.84 |
| Change | - | -58.72% | -50.76% | -67.53% | -234.87% | -118.8% | 40.71% | 74.38% |
| P/E | -22.8x | -7.79x | -3.56x | -4.83x | -2.24x | -1.59x | -1.53x | -1.4x |
| PBR | 4.41x | 3.24x | 2.07x | 1.03x | 0.81x | 0.45x | 0.54x | 0.66x |
| PEG | - | -0.2x | -0.1x | 0.1x | -0.25x | 0.1x | -0.4x | -0.15x |
| Capitalization / Revenue | 153x | 60.8x | 28.4x | 27.4x | 6.77x | 6.39x | 33.1x | 12.5x |
| EV / Revenue | 118x | 39.4x | 10.4x | 2.58x | -1.69x | -7.05x | -21.6x | -2.1x |
| EV / EBITDA | -21.5x | -5.05x | -1.53x | -0.45x | 0.51x | 1.94x | 0.92x | 0.24x |
| EV / EBIT | -21x | -4.89x | -1.48x | -0.43x | 0.5x | 1.55x | 0.85x | 0.2x |
| EV / FCF | -82.1x | -5.42x | -4.42x | -0.55x | 0.49x | 1.91x | 1.04x | 0.26x |
| FCF Yield | -1.22% | -18.4% | -22.6% | -182% | 205% | 52.4% | 96% | 391% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -2.67 | -3.8 | -5.08 | -2.9 | -3.16 | -2.268 | -2.354 | -2.574 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 11.7 | 14.46 | 26.98 | 35.28 | 72.59 | 38.15 | 7.373 | 19.44 |
| EBITDA 1 | -64.21 | -113 | -183.4 | -202.7 | -240.6 | -138.5 | -172.9 | -172.9 |
| EBIT 1 | -65.62 | -116.7 | -189.9 | -209.9 | -247.1 | -173.5 | -188.4 | -208.5 |
| Net income 1 | -66.82 | -112.7 | -180.7 | -169 | -219 | -158.4 | -173.7 | -197.2 |
| Net Debt 1 | -408.8 | -308.8 | -486.3 | -875.5 | -614 | -512.8 | -403.4 | -284.8 |
| Reference price 2 | 60.870 | 29.600 | 18.080 | 14.000 | 7.080 | 3.610 | 3.610 | 3.610 |
| Nbr of stocks (in thousands) | 29,400 | 29,689 | 42,422 | 69,046 | 69,368 | 70,094 | - | - |
| Announcement Date | 01/03/22 | 28/02/23 | 20/02/24 | 25/02/25 | 17/03/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.53x | -7.05x | 1.94x | - | 244M | |
| 18.32x | 6.97x | 13.35x | 1.63% | 69.4B | |
| 30.72x | 8.25x | 27.72x | 0.05% | 57.24B | |
| 39.18x | 6.93x | 20.69x | 0.83% | 57.62B | |
| 34.57x | 3.29x | 14.19x | -.--% | 43.65B | |
| 51.08x | 5.91x | 32.37x | -.--% | 44.03B | |
| -18.44x | 177.78x | -19.56x | -.--% | 38.08B | |
| 36.57x | 9x | 23.45x | 0.36% | 36.31B | |
| 44.16x | 7.87x | 26.34x | -.--% | 32.61B | |
| 29.41x | 6.22x | 16.14x | -.--% | 25.47B | |
| Average | 26.40x | 22.52x | 15.66x | 0.32% | 40.47B | |
| Weighted average by Cap. | 29.31x | 22.90x | 17.61x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BCYC Stock
- Valuation Bicycle Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
